# CAMCEVI

NDC: 69448-014
Generic name: LEUPROLIDE
Labeler / Manufacturer: Accord BioPharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, EMULSION
Routes: SUBCUTANEOUS
Marketing started: 20220405

FDA application: NDA211488

## Active ingredients

- LEUPROLIDE MESYLATE: 42 mg/.37g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69448-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69448-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7a8761a-d953-413a-e053-2a95a90a60ee